Hair Are the Rankings—5-Alpha Reductase Inhibitors and Minoxidil in Male Androgenetic Alopecia

    February 2022 in “ JAMA Dermatology
    Kathie P. Huang, Maryanne M. Senna
    Image of study
    TLDR Minoxidil and finasteride are FDA-approved treatments for male hair loss, but off-label use of oral minoxidil, dutasteride, and higher doses of finasteride and minoxidil is increasing.
    Androgenetic alopecia (AGA) is the most common type of hair loss in men in the US, affecting 50% of men by age 50 and up to 90% of men in their lifetime. It can moderately impair health-related quality of life and is associated with low self-esteem and depression. Currently, the only US Food and Drug Administration-approved therapies for AGA are topical minoxidil, oral finasteride 1 mg, and low-level light therapy. However, due to the high prevalence of AGA and its associated outcomes, there is an increasing trend in the literature reporting off-label use of oral minoxidil, oral dutasteride, and higher doses of oral finasteride and topical minoxidil to expand therapeutic options for patients.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    3 / 3 results